Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $615
Strong Q3 EPS Performance and Robust 2024 Guidance Justify Buy Rating for UnitedHealth
KeyBanc initiates coverage of unitedhealth with a target price of $675.
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $604
UnitedHealth Group Analyst Ratings
TD Cowen Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $601
Barclays Sticks to Their Buy Rating for UnitedHealth (UNH)
Deutsche Bank Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $632
UnitedHealth Group (UNH) Poised for Growth: A Buy Rating With a Favorable 2025 Outlook
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $654
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $615
UnitedHealth's Strategic Positioning and Resilience Amid MA Challenges: A Buy Rating Analysis
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group, Maintains $591 Price Target
UnitedHealth Group Analyst Ratings
Wolfe Research Adjusts Price Target on UnitedHealth to $600 From $589
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group, Maintains $591 Price Target
UnitedHealth Group Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group, Maintains $591 Price Target
BofA Securities Initiates UnitedHealth(UNH.US) With Buy Rating
Bank of America Securities Reaffirms Their Buy Rating on UnitedHealth (UNH)